Factors Associated With Decision Making In the Second-Line Treatment of Patients With Advanced/Metastatic Gastrointestinal Cancers
Podcast 2: Next steps after progression in GEJ cancers: Rechallenging with VEGF-directed therapy

Questions marked with a * are required
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
Edward is a 75 year-old man who presents with an ulcerating mass in the gastric body that is HER2+ and has progressed despite being on first-line therapy. Which of the following are options is most appropriate as second-line therapy?
Follow-up imaging finds new metastatic lesions in the liver. Which of the following statements are true regarding therapy sequencing?
Powered by QuestionPro